The diffuse and discontinuous claudin-5 patterns of immunoreactivity we observed in resected hippocampus and cortex in the temporal lobe of patients with epilepsy suggests BBB dysfunction and claudin-5 dysregulation are key drivers of pathology. The gene discussed is CLDN5; the disease is epilepsy.